Knott David M Jr Eiger Bio Pharmaceuticals, Inc. Transaction History

Knott David M Jr

  • $285 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$4.99 - $8.96 $99,800 - $179,200
20,000 Added 5.14%
409,292 $2.58 Million
Q1 2022

May 16, 2022
BUY
$3.84 - $9.74 $275,712 - $699,332
71,800 Added 22.61%
389,292 $3.23 Million
Q4 2021

Feb 11, 2022
BUY
$5.12 - $8.19 $1.63 Million - $2.6 Million
317,492 New
317,492 $1.65 Million

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $76.1M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email